Head to Head Analysis: Shineco (SISI) and Its Rivals

Shineco (NASDAQ:SISI) is one of 248 public companies in the “MED – DRUGS” industry, but how does it contrast to its peers? We will compare Shineco to similar businesses based on the strength of its risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations.

Volatility & Risk

Shineco has a beta of -1.33, indicating that its share price is 233% less volatile than the S&P 500. Comparatively, Shineco’s peers have a beta of -0.74, indicating that their average share price is 174% less volatile than the S&P 500.

Profitability

This table compares Shineco and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Shineco Competitors	-20,892.98%	-168.28%	-17.95%

Earnings and Valuation

This table compares Shineco and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Shineco	$9.60 million	-$22.45 million	0.00
Shineco Competitors	$30.15 billion	$59.06 million	2.83

Shineco’s peers have higher revenue and earnings than Shineco. Shineco is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

4.1% of Shineco shares are held by institutional investors. Comparatively, 44.1% of shares of all “MED – DRUGS” companies are held by institutional investors. 0.0% of Shineco shares are held by company insiders. Comparatively, 13.5% of shares of all “MED – DRUGS” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Shineco and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1	0	0	0	1.00
Shineco Competitors	2205	3796	9846	410	2.52

As a group, “MED – DRUGS” companies have a potential upside of 59.47%. Given Shineco’s peers stronger consensus rating and higher probable upside, analysts plainly believe Shineco has less favorable growth aspects than its peers.

Summary

Shineco peers beat Shineco on 11 of the 13 factors compared.

About Shineco

Shineco, Inc., through its subsidiaries, processes and distributes agricultural produce. It also engages in the growing and cultivation of mulberry trees and silkworm cocoons; distribution of fruit business; and processing and distribution of silk and silk fabrics, as well as other by-products. The company was incorporated in 1997 and is headquartered in Beijing, the People's Republic of China.